在动物模型中用新型矿物-有机黏合材料稳定过大骨切开术中种植体的十二个月评估
研究在26只犬下颌骨制备过大骨切开术并植入种植体,分别用黏合剂、颗粒异种移植物或血凝块填充间隙。黏合剂组即刻稳定性为22.2 N-cm(95%CI 5.3;39.0),12个月时为171 N-cm(95%CI 134.2;209.4),组织学显示黏合剂与种植体及骨壁紧密接触并被新骨替代,维持边缘骨水平。
要点
- 黏合剂组即刻扭矩22.2 N-cm(95%CI 5.3;39.0),显著高于血凝块组1.4 N-cm和异种移植组1.3 N-cm。
- 9个月和12个月时黏合剂组扭矩分别为155 N-cm和171 N-cm,均高于血凝块组和异种移植组。
- 组织学显示黏合剂被新骨替代,软组织未渗入,边缘骨水平维持;异种移植颗粒部分被结缔组织包裹。
核心结论
- 在过大骨切开术中缺乏初期稳定性的种植体,可在植入时用新型高骨传导性可吸收黏合剂获得稳定。
- 生物材料逐渐被替代,允许骨结合且12个月随访期内不丢失稳定性。
- 该新型黏合剂有潜力稳定植入骨支撑不足位点的种植体。
研究设计与样本
- 在26只犬下颌骨拔牙后双侧制备三个过大骨切开术,植入种植体。
- 种植体与骨间隙分别用黏合剂、颗粒异种移植物或血凝块填充。
- 评估拆除扭矩和组织学。
主要发现
- 黏合剂组即刻扭矩22.2 N-cm(95%CI 5.3;39.0),血凝块组1.4 N-cm(95%CI 0.7;2.1),异种移植组1.3 N-cm(95%CI 0.6;2.0)。
- 9个月时黏合剂组155 N-cm(95%CI 113;197),血凝块组128.6 N-cm(95%CI 66.8;190.4),异种移植组132.1 N-cm(95%CI 94.5;169.7)。
- 12个月时黏合剂组171 N-cm(95%CI 134.2;209.4),血凝块组140.7 N-cm(95%CI 78.8;202.5),异种移植组101.5 N-cm(95%CI 59.5;143.5)。
- 组织学显示黏合剂与种植体及骨壁紧密接触并被新骨替代,软组织未渗入,边缘骨/生物材料水平维持。
- 异种移植或血凝块填充的对照位点愈合后骨水平降低,部分异种移植颗粒被结缔组织包裹。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study is to evaluate long-term in vivo stability of dental implants stabilized at time of placement in oversized osteotomies with a novel, self-setting, mineral-organic bone adhesive. MATERIALS/METHODS: Canine (26) mandibular teeth were removed, and three oversized osteotomies prepared bilaterally. Implants were placed with either adhesive, particulate xenograft, or with blood clot filling the implant/osteotomy gaps. Removal torque and histology were assessed. RESULTS: The adhesive provided significant and clinically relevant immediate implant stability of 22.2 N-cm (95% CI 5.3; 39.0), which continued throughout the early postoperative course and persisted through the nine- (155 N-cm 95% CI 113; 197) and 12-month (171 N-cm 95% CI 134.2; 209.4) time points. This is in comparison with the blood clot of 1.4 N-cm (95% CI 0.7; 2.1), 128.6 N-cm (95% CI 66.8; 190.4), and 140.7 N-cm (95% CI 78.8; 202.5) and particulate xenograft, 1.3 N-cm (95% CI 0.6; 2.0), 132.1 N-cm (95% CI 94.5; 169.7), and 101.5 (95% CI 59.5; 143.5), respectively. Histological examination shows the adhesive establishes intimate contact with the implant and bony walls and is replaced with new bone without compromising stability. Soft tissue does not penetrate the adhesive, and marginal bone/biomaterial level is maintained. Control sites filled with xenograft or blood clot heal with reduced bone levels, and in some cases, xenograft particles were encapsulated in connective tissue. CONCLUSIONS: Implants placed in oversized osteotomies and lacking primary stability can be stabilized at placement with a novel, highly osteoconductive, and resorbable adhesive. Gradual replacement of the biomaterial allows osseointegration without loss of stability through 12 months of follow-up. This novel adhesive has the potential to stabilize implants placed in sites with inadequate bony support.
引用
- Cochran DL, Jones AA, Sugita R, et al. Twelve-month evaluation of a novel mineral-organic adhesive material used to stabilize dental implants placed in oversized osteotomies in vivo in an animal model. Clin Oral Implants Res. 2022. PMID: 35132693. doi:10.1111/clr.13899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。